• Stock Chart

    Stock Chart

    Oragenics, Inc.(OGEN)

    NYSE American

    $0.634

    0.0143(2.308%)

    OGEN Company Profile

    4902 Eisenhower boulevard

    Tampa, FL 33634
    1.813.286.7900
    http://www.oragenics.com
    Sector: Health Technology
    Industry: Biotechnology
    Full Time Employees: 7

    Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

    • Previous Close
      0.6197
    • Open
      0.601
    • Bid
    • Ask
    • Day's Range
      0.601 - 0.6499
    • 52 week Range
      0.36 - 2.09
    • Volume
      758714
    • Avg. Volume
      2551285
    • Market Cap
      38677107
    • Beta (5Y Monthly)
      0.601
    • PE Ratio (TTM)
      -1.24
    • EPS (TTM)
    • Earnings Date
      0.601
    • Forward Dividend & Yield
      0.601
    • Ex-Dividend Date
      758714
    • 1y Target Est
      0.601

    KEEP ME INFORMED ON OGEN UPDATES

    OGEN Performance

    • 5 Day
      -9.4286%
    • 1 Month
      -16.469%
    • 3 Month
      13.3357%
    • YTD
      25.1975%
    • 1 Year
      16.0747%

    OGEN on Twitter

    OGEN on iHub

    OGEN News

    /*
  • */